Prof. Amnon Peled, PhD
Prof. Peled is Associate Professor and the Head of the Gene Therapy Institute at Hadassah Medical Center, Jerusalem, where he directs a laboratory focusing on the role of cytokine in hematopoietic stem cell biology, inflammation, and cancer. For over 20 years, Prof. Peled has been involved in developing novel therapies with Biokine Therapeutics (where he is founder and Chief Scientific Officer), BiolineRX (NASDAQ: BLRX), Gamida Cell (NASDAQ: GMDA), and others. He has co-authored more than 110 publications and is inventor or co-inventor of more than 180 patents related to therapeutic applications in stem cell biology, immunology, and cancer. Prof. Peled holds a Ph.D. from the Department of Cell Biology at the Weizmann Institute of Science and did his post-doc at Harvard Medical School.